Neulasta

Latest stories

5d
Pacific Coast Business Times
FDA declines to approve Novartis biosimilar for Amgen’s NeulastaThe Food and Drug Administration has declined for now to approve a copycat vers
FDA declines to approve Novartis biosimilar for Amgen’s Neulasta
Pacific Coast Business Times / Posted 5 days ago
The Food and Drug Administration has declined for now to approve a copycat version of Amgen’s blockbuster drug Neulasta. Reuters reported July 19 that the FDA sent a letter to Swiss pharmaceutical Novartis at the end of June saying it was declining... Read more
3 related stories
5d
Fortune
Amgen Finally Scores a Win In Its Big Copycat Drug Battle With Novartishave rejected one of its experimental drugs, a copycat version of Amgen’s amgn
Amgen Finally Scores a Win In Its Big Copycat Drug Battle With Novartis
Fortune / Posted 5 days ago
have rejected one of its experimental drugs, a copycat version of Amgen’s amgn cancer patient white blood cell-booster Neulasta. The Food and Drug Administration’s (FDA) rejection of Novartis’ biosimilar therapy is welcome news for Amgen,... Read more
3 related stories

People in this news